This innovative software, CRISPRware, optimizes guide RNA design for genome editing, supporting research on genetic disorders ...

Industrial sectors are on the cusp of major changes, driven by new tech. It’s not just about doing things faster; it’s about ...

A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

When doctors use the term “sickle cell anemia,” they are often referring to HbSS. Hemoglobin SC (HbSC) About 1 in 4 people with sickle cell disease have HbSC, which is mild to moderate.

Sickle cell anemia, a hereditary blood disorder, affects millions globally, predominantly among those of African, ...

Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

As a result of being a caregiver for her cousin, columnist Sylvia Amuta says she's now more caring, compassionate, and kind to others.

Mar. 5, 2024 — A novel screening system enables researchers to investigate sperm cell development and health at the molecular level. The new approach promises breakthroughs in male contraception ...